insights_auto
Why is PEB up 6.98%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.23
arrow_upward
+6.98%(+0.015) 1D
Nov 13, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.22
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
57.84K
Volume
51.56K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.22
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
57.84K
Volume
51.56K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
BigGo Finance
·
56 minutes ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
22 hours ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Longbridge
·
2 days ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
Traders Union
·
3 hours ago
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com